AS ONE Corporation (TYO:7476)
Japan
· Delayed Price · Currency is JPY 2,410.00
+25.00 (1.05%)
Jun 6, 2025, 3:30 PM JST
AS ONE Revenue
In the fiscal year ending March 31, 2025, AS ONE had annual revenue of 103.75B JPY with 8.60% growth. AS ONE had revenue of 28.38B in the quarter ending March 31, 2025, with 5.56% growth.
Revenue
103.75B
Revenue Growth
+8.60%
P/S Ratio
1.66
Revenue / Employee
145.92M
Employees
711
Market Cap
172.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 103.75B | 8.22B | 8.60% |
| Mar 31, 2024 | 95.54B | 4.12B | 4.50% |
| Mar 31, 2023 | 91.42B | 4.47B | 5.14% |
| Mar 31, 2022 | 86.95B | 5.35B | 6.55% |
| Mar 31, 2021 | 81.61B | 11.22B | 15.94% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |